SARAH PRICE CANINE PHYSIOTHERAPY LIMITEDActive

Company number 06861349Private limited companyIncorporated 2009

Key figures

£312-93.0%
Net assets 2025/26
-34.7%
Average annual change 2020/21–2025/26
05 k10 k15 k20 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, SARAH PRICE CANINE PHYSIOTHERAPY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k30 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Total assets29,08925,31319,37221,53018,811
Total liabilities22,5228,0289,36917,04618,499
Net assets / total equity6,56717,28510,0034,484312
Average number of employees00111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

75000

As described in the company's latest filed accounts.

Summary: SARAH PRICE CANINE PHYSIOTHERAPY LIMITED

Company

SARAH PRICE CANINE PHYSIOTHERAPY LIMITED is a private limited company registered with Companies House under company number 06861349. It was incorporated on 27 Mar 2009. Its status is active. The registered office is in Ross-on-wye (HR9). Its nature of business (SIC 2007) is veterinary activities (75000).

Accounts

The latest accounts in the database are for 2025/26 (period ending 5 Apr 2026); the company files micro-entity accounts. Net assets were £312, down 93% on the previous year. Total assets were £18,811 and total liabilities £18,499. The company had an average of 1 employee. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 5 Jan 2028. The next confirmation statement is due by 10 Apr 2027.